Success for EndoFLIP!
Cropson’s EndoFLIP has had it’s first use in a new weight loss surgery technique, known as gastric imbrications.
The reversible gastric imbrications technique is a unique procedure that needs no device implanted or no tissue removed from the stomach.
The potential for success in the US is quite realistic, given the popularity for weight loss surgery in the US.
“The EndoFLIP device has the avility to change the way we do bariatric surgery all over the world” says Dr Daniel Cottam, “There has been nothing as revolutionary as this device since the lap band”.
Cottam added “I believe in five years we won’t know how we ever did bariatric surgery without it”.
EndoFLIP technology “fills an important need for the gastric imbrications procedure, namely providing visual feedback to the surgeon “, John O Dea, CEO Crospon as said.
Once again, we wish Crospon the very best of luck with their venture in the US.
Watch this space for further EndoFLIP updates!
